ARCB
ArcBest Corporation
ARCB has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over ARCB overall, supported by stronger valuation and stronger fundamentals.
ARCB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
ARCB's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
ARCB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $10.60 | -92% |
| Forward | 14x | $135 | — |
| Fair | 15x | $18.93 | -86% |
| Expensive | 28x | $35.29 | -74% |
| Current | 105x | $135 | — |
Historical ranges are pointers, not guarantees.
ARCB's PE is in its expensive range at 105x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over ARCB in the historical PE scenario, which offers more potential upside but is not a forecast.
ARCB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARCB, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
ARCB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.38 | +633% |
| Q3 2026 | $1.28 | -69% |
| Q2 2026 | $0.70 | -90% |
| Q1 2026 | $2.44 | -68% |
| Q4 2025 | $2.62 | -64% |
| Q3 2025 | $4.18 | -49% |
| Q2 2025 | $6.69 | +26% |
| Q1 2025 | $7.53 | +51% |
| Q4 2024 | $7.30 | -7.9% |
ARCB's earnings per share have fallen from their peak: $1.28 over the past year, against $12.64 in late 2022.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over ARCB on earnings, with more consistent year-over-year improvement.
ARCB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +15% |
| Q2 2026 | $1.2B | +16% |
| Q1 2026 | $998.8M | +3.3% |
| Q4 2025 | $972.7M | -2.9% |
| Q3 2025 | $1B | -1.4% |
| Q2 2025 | $1B | -5.2% |
| Q1 2025 | $967.1M | -6.7% |
| Q4 2024 | $1B | -8.1% |
ARCB's revenue is growing: $1.2B last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.1% | +0.8 points |
| Q2 2026 | -1.7% | -5.4 points |
| Q1 2026 | 0.3% | -0.3 points |
| Q4 2025 | -0.8% | -4.7 points |
| Q3 2025 | 5.2% | -7.5 points |
| Q2 2025 | 3.6% | -0.9 points |
| Q1 2025 | 0.7% | -1.5 points |
| Q4 2024 | 3.8% | -2.1 points |
ARCB's operating margin was 6.1% last quarter, up 0.8 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over ARCB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over ARCB on profitability, with a higher operating margin.
ARCB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $103.3M | +211% |
| Q2 2026 | $117.1M | +45% |
| Q1 2026 | -$1.2M | +$35.6M |
| Q4 2025 | $36.9M | +944% |
| Q3 2025 | $33.2M | +39% |
| Q2 2025 | $80.9M | -3.5% |
| Q1 2025 | -$36.8M | +$11.7M |
| Q4 2024 | $3.5M | -91% |
ARCB generated $256M in free cash flow over the past year, about three times what it generated the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over ARCB on cash flow, with more consistent year-over-year improvement.
ARCB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +79.5K shares |
| 1 year | -1.7% | -383K shares |
| 3 years | -8.6% | -2.1M shares |
| 5 years | -16% | -4.3M shares |
| Available history | -12% | -3.1M shares |
ARCB has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $26.6M |
| Q2 2026 | $749,000 |
| Q1 2026 | $7.4M |
| Q4 2025 | $17.4M |
| Q3 2025 | $16.4M |
| Q2 2025 | $19.7M |
| Q1 2025 | $22M |
| Q4 2024 | $19.1M |
ARCB spent $52M buying back its own shares over the past year, down 32% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
ARCB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.2x | Very low |
ARCB's net debt is less than a year of its operating earnings (EBITDA).
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over ARCB on leverage, with a lower net debt burden relative to earnings.
ARCB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 24.0 | Neutral |
ARCB's weekly RSI is 53 (neutral) and its Stochastic is 24 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
ARCB PE vs Industrials Sector
| Metric | ARCB | Sector median | Relative |
|---|---|---|---|
| PE | 105x | 24x | 338% above |
| PE % | 96 | 58 | 38 pts above |
ARCB is trading at 105x earnings, a 338% premium to the Industrials sector's median of 24x.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT has the edge over ARCB on valuation relative to its sector.
ARCB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $129.0 | 4.3% above |
| 20 week MA | $137.0 | 1.8% below |
| 50 week MA | $119.2 | 13% above |
| 100 week MA | $97.1 | 39% above |
| 200 week MA | $102.9 | 31% above |
ARCB has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
ARCB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.4 | $43.3 | +58% |
| 2021 | $43.3 | $111.6 | +158% |
| 2022 | $111.6 | $71.5 | -36% |
| 2023 | $71.5 | $120.2 | +68% |
| 2024 | $120.2 | $93.6 | -22% |
| 2025 | $93.6 | $77.3 | -17% |
| 2026 YTD | $77.3 | $134.6 | +74% |
ARCB has the edge over VRT on returns for 2026, with the stronger performance.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT's yearly returns have swung widely, from +275% in 2023 to −48% in 2022. It's up 25% so far in 2026.